Significance of Body Mass Index in the Classification of PCOS: A Comparative Study in Northeast India
Swapna S Pillai, Prasanta Dihingia
Citation Information :
Pillai SS, Dihingia P. Significance of Body Mass Index in the Classification of PCOS: A Comparative Study in Northeast India. J South Asian Feder Obs Gynae 2020; 12 (3):145-149.
Aim: To compare the clinical and biochemical characteristics of obese and lean women with polycystic ovary syndrome (PCOS). To confirm the significance of body mass index (BMI) in classifying PCOS. Materials and methods: This was a comparative cross-sectional study done at Assam Medical College Hospital, Dibrugarh, Assam, in 1 year. Women who attended the hospital diagnosed to have PCOS based on Rotterdam's criteria were divided into lean and obese with BMI cut-off of 23. Clinical, anthropometric, and biochemical characteristics of both were compared. Body fat percentage was calculated using Harpenden skinfold calipers, and based on it, the lean group was found to have a normal weight, and obese subgroup with body fat percentage more than the cut-off. Result: There was a significant difference in age, hirsutism score, and family history of diabetes and PCOS between the groups. The systolic blood pressure, serum cholesterol, and serum low-density lipoprotein (S.LDL) were statistically higher in the obese group. The normal weight obese group had features of the lean group, except for hyperandrogenism. Conclusion: The lean and obese PCOS are two discrete groups. Obese patients have a more androgenic and atherogenic lipid profile, but both groups should be screened. Body mass index is the easily available method, but it has a chance of missing out on the normal weight obese PCOS. Clinical significance: Follow-up is needed in both the groups, and the normal weight obese group behaves as the lean PCOS group; hence, BMI can be continued to be used as the differentiating factor.
Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2009;2(1):12–17. DOI: 10.4103/0974-1208.51336.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19–25. DOI: 10.1016/j.fertnstert.2003.10.004.
The Potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab 2015;100(3):911–919. DOI: 10.1210/jc.2014-3886.
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12(6):673–683. DOI: 10.1093/humupd/dml036.
Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28(2):341–359. DOI: 10.1016/S0889-8529(05)70073-6.
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992;57(3):505–513. DOI: 10.1016/S0015-0282(16)54892-4.
Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 2010;34(5):791–799. DOI: 10.1038/ijo.2010.5.
The relationship between BMI and percent body fat, measured by bioelectrical impedance, in a large adult sample is curvilinear and influenced by age and sex. Clin Nutr 2010;29(5):560–566. DOI: 10.1016/j.clnu.2009.12.011.
Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157–163. DOI: 10.1016/S0140-6736(03)15268-3.
A case control study of role of lipid profile in polycystic ovarian syndrome: is there any role in non-obese polycystic ovary syndrome? Int J Reprod Contracept Obstet Gynecol 2016;5(6):1981–1984.
Sensitivity and specificity of the Quetelet index to assess obesity in men and women. Eur J Clin Nutr 1994;48(5):369–375.
Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome. Hormones 2015;14(3):431–437.
Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 2009;92(6):1960–1965. DOI: 10.1016/j.fertnstert.2008.09.003.
Metabolic concomitants of obese and nonobese women with features of polycystic ovarian syndrome. J Endocr Soc 2017;1(12):1417–1427. DOI: 10.1210/js.2017-00323.
Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study. J Biomed Res 2016;30(3):197–202.
Obese and non-obese polycystic ovarian syndrome: comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene. Indian J Endocrinol Metab 2019;23(2):257. DOI: 10.4103/ijem.IJEM_637_18.
Comparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index. Int J Reprod Contracept Obstet Gynecol 2016;5(8):2561–2565.
